Humira and Amcinonide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Humira (adalimumab) and Amcinonide (amcinonide). Common drug interactions include nasopharyngitis among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Humira and Amcinonide. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Humira?

Humira has active ingredients of adalimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 761,396 Humira users. Check the latest studies of Humira.

What is Amcinonide?

Amcinonide has active ingredients of amcinonide. eHealthMe is studying from 152 Amcinonide users. Check the latest studies of Amcinonide.



On Jul, 15, 2026

13 people who take Humira and Amcinonide together, and have interactions are studied.

Humira and Amcinonide drug interactions.

What are the common drug interactions of Humira and Amcinonide, by gender? *:

female:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Arthralgia (joint pain)
  3. Cyst (a closed sac)
  4. Cyst rupture (fluid leakage from sac)
  5. Cystitis (inflammation of the wall of the bladder)
  6. Drug ineffective
  7. Fungal infection
  8. Gait disturbance
  9. Infection
  10. Inflammation

male:

  1. Arthralgia (joint pain)
  2. Arthropathy
  3. Nail disorder (disease of nail)
  4. Pain in extremity
  5. Peptic ulcer
  6. Psoriasis (immune-mediated disease that affects the skin)
  7. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  8. Pulmonary fibrosis (formation or development of excess fibrous connective tissue (fibrosis) in the lungs)
  9. Skin disorder (skin disease)
  10. Swelling

What are the common drug interactions of Humira and Amcinonide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthralgia (joint pain)
  2. Cyst (a closed sac)
  3. Cyst rupture (fluid leakage from sac)
  4. Cystitis (inflammation of the wall of the bladder)
  5. Drug ineffective
  6. Fungal infection
  7. Gait disturbance
  8. Infection
  9. Inflammation
  10. Injection site haemorrhage (bleeding from injection site)

40-49:

n/a

50-59:

  1. Arthropathy
  2. Atelectasis (partial or complete collapse of the lung)
  3. Bone erosion
  4. Finger deformity (a deformed position of the finger)
  5. Grip strength decreased
  6. Hypertension (high blood pressure)
  7. Joint instability (a condition in which the joints aren't sufficiently supported)
  8. Muscular weakness (muscle weakness)
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Nail disorder (disease of nail)

60+:

  1. Discomfort
  2. Dyspnoea (difficult or laboured respiration)
  3. Fatigue (feeling of tiredness)
  4. Headache (pain in head)
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Nasopharyngitis (inflammation of the nasopharynx)
  8. Nerve compression
  9. Synovial cyst (cyst of joint filled with synovial fluid)

What are the existing conditions these people have? *

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 13 people, 100.00%
  2. Psoriasis (immune-mediated disease that affects the skin): 8 people, 61.54%
  3. Ankylosing Spondylitis (type of arthritis affecting the spine): 7 people, 53.85%
  4. Osteoporosis (bones weak and more likely to break): 1 person, 7.69%
  5. High Blood Pressure: 1 person, 7.69%
  6. High Blood Cholesterol: 1 person, 7.69%
  7. Headache (pain in head): 1 person, 7.69%
  8. Diabetes: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Humira and Amcinonide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Humira and Amcinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Humira:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Amcinonide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humira and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amcinonide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on adalimumab and amcinonide (the active ingredients of Humira and Amcinonide, respectively), and Humira and Amcinonide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: